Both authors contributed equally to the work.
Molecular Analysis of Myophosphorylase Deficiency in Dutch Patients with McArdle's Disease
Version of Record online: 29 JAN 2004
Annals of Human Genetics
Volume 68, Issue 1, pages 17–22, January 2004
How to Cite
Martín, M. A., Rubio, J. C., Wevers, R. A., Van Engelen, B. G. M., Steenbergen, G. C. H., Van Diggelen, O. P., Visser, M. D., Die-Smulders, C. D., Blázquez, A., Andreu, A. L. and Arenas, J. (2004), Molecular Analysis of Myophosphorylase Deficiency in Dutch Patients with McArdle's Disease. Annals of Human Genetics, 68: 17–22. doi: 10.1046/j.1529-8817.2003.00067.x
- Issue online: 29 JAN 2004
- Version of Record online: 29 JAN 2004
- Received: 4 March 2003 Accepted: 8 August 2003
We report on 8 Dutch patients with McArdle's disease from 6 unrelated families. Molecular analysis revealed the presence of four previously described mutations: the common R49X mutation, the IVS14+1G>A mutation and the recently reported R269X and Y84X nonsense mutations; and two new molecular defects: a missense mutation R138W in the homozygous state in two siblings, and a frameshift mutation c.1797delT. This first genetic study of patients from The Netherlands with McArdle's disease confirms that the R49X mutation is also the most common in Dutch patients, and that there is genetic heterogeneity within this population. Moreover, our data support the hypothesis that the Y84X mutation is a relatively frequent mutation in McArdle's patients with a Central European background, and expand the already crowded map of mutations within the PYGM gene responsible for McArdle's disease.